Evidence map›Paper›PMID 37491435›Full record

ArticleNature communications2023

Supersulphides provide airway protection in viral and chronic lung diseases.

Tetsuro Matsunaga, Hirohito Sano, Katsuya Takita, Masanobu Morita, Shun Yamanaka, Tomohiro Ichikawa, Tadahisa Numakura, Tomoaki Ida, Minkyung Jung, Seiryo Ogata and 21 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Silver Tip (International journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Pulmonary fibrosis: from mechanisms to therapies.Journal of translational medicine · 2025
    Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 5 institutions in 2 countries.

Tetsuro Matsunaga *Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.ORCID 0000-0003-2944-3326
Hirohito Sano *Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.ORCID 0000-0003-2285-7577
Katsuya Takita *Department of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Masanobu Morita *Department of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
Shun YamanakaDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Tomohiro IchikawaDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Tadahisa NumakuraDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Tomoaki IdaDepartment of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.ORCID 0000-0002-4443-6127
Minkyung JungDepartment of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
Seiryo OgataDepartment of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
Sunghyeon YoonDepartment of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
Naoya FujinoDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.ORCID 0000-0003-3174-2632
Yorihiko KyogokuDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Yusaku SasakiDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Akira KoaraiDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.ORCID 0000-0001-9147-4225
Tsutomu TamadaDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Atsuhiko ToyamaAnalytical and Measuring Instruments Division, Shimadzu Corporation, Kyoto, 604-8511, Japan.
Takakazu NakabayashiBio-Structural Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan.
Lisa KageyamaBio-Structural Chemistry, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan.ORCID 0000-0001-9536-2466
Shigeru KyuwaLaboratory of Biomedical Science, Department of Veterinary Medical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, 113-8657, Japan.
Kenji InabaInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai, 980-8577, Japan.ORCID 0000-0001-8229-0467
Satoshi WatanabeInstitute of Multidisciplinary Research for Advanced Materials, Tohoku University, Sendai, 980-8577, Japan.
Péter NagyDepartment of Molecular Immunology and Toxicology, National Institute of Oncology, Budapest, 1122, Hungary.ORCID 0000-0003-3393-235X
Tomohiro SawaDepartment of Microbiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 860-8556, Japan.
Hiroyuki OshiumiDepartment of Immunology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, 860-8556, Japan.ORCID 0000-0003-1567-8722
Masakazu IchinoseDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
Mitsuhiro YamadaDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.ORCID 0000-0002-0832-1939
Hisatoshi SugiuraDepartment of Respiratory Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan. sugiura@rm.med.tohoku.ac.jp.ORCID 0000-0002-4335-7048
Fan-Yan WeiDepartment of Modomics Biology and Medicine, Institute of Development, Aging and Cancer, Tohoku University, Sendai, 980-8575, Japan.ORCID 0000-0002-4843-724X
Hozumi MotohashiDepartment of Gene Expression Regulation, Institute of Development, Aging and Cancer, Tohoku University, Sendai, 980-8575, Japan. hozumim@med.tohoku.ac.jp.ORCID 0000-0002-7261-1033
Takaaki AkaikeDepartment of Environmental Medicine and Molecular Toxicology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan. takaike@med.tohoku.ac.jp.ORCID 0000-0002-0623-1710
Tohoku University · JPKumamoto University · JPNational Institute of Oncology · HUShimadzu (Japan) · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Supersulphides are inorganic and organic sulphides with sulphur catenation with diverse physiological functions. Their synthesis is mainly mediated by mitochondrial cysteinyl-tRNA synthetase (CARS2) that functions as a principal cysteine persulphide synthase (CPERS). Here, we identify protective functions of supersulphides in viral airway infections (influenza and COVID-19), in aged lungs and in chronic lung diseases, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF). We develop a method for breath supersulphur-omics and demonstrate that levels of exhaled supersulphides increase in people with COVID-19 infection and in a hamster model of SARS-CoV-2 infection. Lung damage and subsequent lethality that result from oxidative stress and inflammation in mouse models of COPD, IPF, and ageing were mitigated by endogenous supersulphides production by CARS2/CPERS or exogenous administration of the supersulphide donor glutathione trisulphide. We revealed a protective role of supersulphides in airways with various viral or chronic insults and demonstrated the potential of targeting supersulphides in lung disease.

Indexed as

COVID-19Idiopathic Pulmonary FibrosisPulmonary Disease, Chronic ObstructiveAnimalsLungMiceSARS-CoV-2

Identifiers

PMID37491435
PMCPMC10368687
OpenAlexW4385260384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.